It seems we can’t find what you’re looking for. Perhaps searching can help.
It seems we can’t find what you’re looking for. Perhaps searching can help.
Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Learn MoreSILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.
Read moreSDC Technologies has expanded its investment in flō Optics and will join the company’s Board, strengthening their strategic partnership and supporting commercialization of digital coating technologies.
Read moreSightGlass Vision announces that two million children worldwide now wear DOT™ lenses, marking rapid adoption of contrast management myopia control technology.
Read moreDrip turns colour into wearable art with layered patterns, hand-painted details and sculpted acetate, balanced by flexible spring hinges designed for active kids.
Read more
Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Learn MoreSILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.
Read MoreSDC Technologies has expanded its investment in flō Optics and will join the company’s Board, strengthening their strategic partnership and supporting commercialization of digital coating technologies.
Read MoreSightGlass Vision announces that two million children worldwide now wear DOT™ lenses, marking rapid adoption of contrast management myopia control technology.
Read MoreDrip turns colour into wearable art with layered patterns, hand-painted details and sculpted acetate, balanced by flexible spring hinges designed for active kids.
Read More
Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Learn MoreSILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.
Read moreSDC Technologies has expanded its investment in flō Optics and will join the company’s Board, strengthening their strategic partnership and supporting commercialization of digital coating technologies.
Read moreSightGlass Vision announces that two million children worldwide now wear DOT™ lenses, marking rapid adoption of contrast management myopia control technology.
Read moreDrip turns colour into wearable art with layered patterns, hand-painted details and sculpted acetate, balanced by flexible spring hinges designed for active kids.
Read more
Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Learn MoreSILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.
Read moreSDC Technologies has expanded its investment in flō Optics and will join the company’s Board, strengthening their strategic partnership and supporting commercialization of digital coating technologies.
Read moreSightGlass Vision announces that two million children worldwide now wear DOT™ lenses, marking rapid adoption of contrast management myopia control technology.
Read moreDrip turns colour into wearable art with layered patterns, hand-painted details and sculpted acetate, balanced by flexible spring hinges designed for active kids.
Read more